Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "bundlepackageleaflet-es-dcaa4d32aa6658a8df831551503e52ee",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"
]
},
"language" : "es",
"identifier" : {
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "EU/1/97/049/001-pt"
},
"type" : "document",
"timestamp" : "2023-06-27T10:09:22Z",
"entry" : [
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-es-873a1a47330e628770640f9c96c0761e",
"resource" : {
"resourceType" : "Composition",
"id" : "composition-es-873a1a47330e628770640f9c96c0761e",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"
]
},
"language" : "es",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"es\" lang=\"es\"><a name=\"Composition_composition-es-873a1a47330e628770640f9c96c0761e\"> </a><p><b>Generated Narrative: Composition</b><a name=\"composition-es-873a1a47330e628770640f9c96c0761e\"> </a><a name=\"hccomposition-es-873a1a47330e628770640f9c96c0761e\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceComposition "composition-es-873a1a47330e628770640f9c96c0761e" (Language "es") </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/rmswi/</code>/karvea-es</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>category</b>: Raw <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-epicategory-cs.html\">Category of EPI</a>#R)</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p><p><b>title</b>: TEST PURPOSES ONLY - Karvea 75 mg tablet</p><h3>Attesters</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style=\"display: none\">*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-composition-attestation-mode.html\">Composition Attestation Mode</a>#official)</span></td><td>2022-02-16 13:28:17+0000</td></tr></table></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"value" : "karvea-es"
}
],
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "Package Leaflet"
},
"category" : [
{
"coding" : [
{
"system" : "http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs",
"code" : "R",
"display" : "Raw"
}
]
}
],
"subject" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"date" : "2022-02-16T13:28:17Z",
"author" : [
{
"reference" : "Organization/mah-511671db37e83e520b00f8a0d817dc96"
}
],
"title" : "TEST PURPOSES ONLY - Karvea 75 mg tablet",
"attester" : [
{
"mode" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/composition-attestation-mode",
"code" : "official"
}
]
},
"time" : "2022-02-16T13:28:17Z"
}
],
"section" : [
{
"title" : "B. PROSPECTO",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "B. PROSPECTO"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
},
"emptyReason" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason",
"code" : "unavailable"
}
]
},
"section" : [
{
"title" : "PROSPECTO: INFORMACIÓN PARA EL USUARIO",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "PROSPECTO: INFORMACIÓN PARA EL USUARIO"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><a name=\"page1\" id=\"page1\"></a><strong><span>Prospecto: información para el usuario</span></strong></p><p><span> </span></p><p><strong><span>Biktarvy 50 mg/200 mg/25 mg comprimidos recubiertos con película</span></strong></p><p><span> </span></p><p><span>bictegravir/emtricitabina/tenofovir alafenamida</span></p><p><span> </span></p><p><span> </span></p><p><strong><span>Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.</span></strong></p><p><span> </span></p><ul><li><span>Conserve este prospecto, ya que puede tener que volver a leerlo.</span></li><li><span>Si tiene alguna duda, consulte a su médico o farmacéutico.</span></li><li><span>Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.</span></li><li><span>Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.</span></li></ul><p><span> </span></p></div>"
}
},
{
"title" : "Contenido del prospecto",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "Contenido del prospecto"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><strong><span>Contenido del prospecto</span></strong></p><p><span> </span></p><ol><li><span>Qué es Biktarvy y para qué se utiliza</span></li><li><span>Qué necesita saber antes de empezar a tomar Biktarvy</span></li><li><span>Cómo tomar Biktarvy</span></li><li><span>Posibles efectos adversos</span></li><li><span>Conservación de Biktarvy</span></li><li><span>Contenido del envase e información adicional</span></li></ol><p><span> </span></p><p><span> </span></p></div>"
}
},
{
"title" : "1. Qué es Karvea y para qué se utiliza",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "1. Qué es Karvea y para qué se utiliza"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><span> </span></p><p><span>Biktarvy contiene tres principios activos:</span></p><ul><li><strong><span>bictegravir,</span></strong> <span>un medicamento antirretroviral conocido como inhibidor de la transferencia de las</span> <span>hebras de la integrasa (INI)</span></li><li><strong><span>emtricitabina,</span></strong> <span>un medicamento antirretroviral de un tipo conocido como nucleósido inhibidor</span> <span>de la transcriptasa inversa (ITIAN)</span></li><li><strong><span>tenofovir alafenamida,</span></strong> <span>un medicamento antirretroviral de un tipo conocido como nucleótido</span> <span>inhibidor de la transcriptasa inversa (ITIANt)</span></li></ul><p><span> </span></p><p><span>Biktarvy es un comprimido único para el tratamiento de la infección por el virus de la inmunodeficiencia humana 1 (VIH-1) en adultos.</span></p><p><span> </span></p><p><span>Biktarvy reduce la cantidad de VIH presente en el organismo. Esto mejora el sistema inmunitario y disminuye el riesgo de desarrollar enfermedades asociadas con la infección por el VIH.</span></p><p><span> </span></p></div>"
}
},
{
"title" : "2. Qué necesita saber antes de empezar a tomar Karvea",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "2. Qué necesita saber antes de empezar a tomar Karvea"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><span> </span></p><p><strong><span>No tome Biktarvy</span></strong></p><p><span> </span></p><ul><li><strong><span>Si es alérgico a bictegravir, emtricitabina, tenofovir alafenamida</span></strong> <span>o a alguno de los demás</span> <span>componentes de este medicamento (incluidos en la sección 6 de este prospecto).</span></li></ul><ul><li><a name=\"page2\" id=\"page2\"></a><strong><span>Si actualmente está tomando alguno de los siguientes medicamentos:</span></strong></li><li><ul><li><strong><span>rifampicina</span></strong> <span>utilizada para tratar algunas infecciones bacterianas como la tuberculosis</span></li><li><strong><span>hierba de San Juan</span></strong> <span>(</span><em><span>Hypericum perforatum</span></em><span>, hipérico), un medicamento a base de</span> <span>plantas utilizado para la depresión y la ansiedad, o productos que la contengan.</span></li></ul></li></ul><p><span> </span></p><ul><li><span>Si está tomando alguno de estos medicamentos,</span> <strong><span>no tome Biktarvy y consulte a su médico</span></strong> <strong><span>inmediatamente.</span></strong></li></ul><p><span> </span></p><p><strong><span>Advertencias y precauciones</span></strong></p><p><span> </span></p><p><strong><span>Consulte a su médico antes de empezar a tomar Biktarvy:</span></strong></p><p><span> </span></p><ul><li><strong><span>Si tiene problemas hepáticos o antecedentes de enfermedad hepática, incluida la hepatitis.</span></strong> <span>Los pacientes que padecen de enfermedades hepáticas, como la hepatitis B o C crónica, y están en tratamiento con antirretrovirales tienen más riesgo de presentar complicaciones hepáticas graves y potencialmente mortales. Si tiene infección por el virus de la hepatitis B, su médico evaluará detenidamente la mejor pauta terapéutica para usted.</span></li></ul><p><span> </span></p><ul><li><strong><span>Si tiene hepatitis B.</span></strong> <span>Los problemas hepáticos pueden empeorar después de dejar de tomar</span> <span>Biktarvy.</span></li></ul><ul><li><span>No deje de tomar Biktarvy si tiene hepatitis B. Hable antes con su médico. Puede consultar más detalles en la sección 3,</span> <em><span>No interrumpa el tratamiento con Biktarvy.</span></em></li></ul><p><span> </span></p><p><strong><span>Mientras esté tomando Biktarvy</span></strong></p><p><span> </span></p><p><span>Una vez que empiece a tomar Biktarvy, esté atento a:</span></p><p><span> </span></p><ul><li><strong><span>Signos de inflamación o infección</span></strong></li><li><strong><span>Dolor articular, rigidez o problemas óseos</span></strong></li></ul><p><span> </span></p><ul><li><strong><span>Si nota cualquiera de estos síntomas, informe a su médico inmediatamente.</span></strong> <span>Puede consultar</span> <span>más información en la sección 4,</span> <em><span>Posibles efectos adversos</span></em><span>.</span></li></ul><p><span> </span></p><p><span>Aunque no se han observado problemas renales con Biktarvy, existe la posibilidad de que pueda experimentar problemas renales si toma Biktarvy durante un periodo de tiempo prolongado.</span></p><p><span> </span></p><p><span>Mientras esté tomando este medicamento</span> <strong><span>aún puede transmitir el VIH a los demás,</span></strong> <span>aunque un tratamiento antirretroviral eficaz reduzca el riesgo. Consulte a su médico sobre qué precauciones son necesarias para no infectar a otras personas. Este medicamento no es una cura para la infección por el VIH. Mientras usted esté tomando Biktarvy podrá seguir padeciendo infecciones u otras enfermedades asociadas con la infección por el VIH.</span></p><p><span> </span></p><p><strong><span>Niños y adolescentes</span></strong></p><p><span> </span></p><p><strong><span>No administre este medicamento a niños y adolescentes menores de 18 años de edad.</span></strong> <span>No se ha</span> <span>estudiado todavía el uso de Biktarvy en niños y adolescentes menores de 18 años de edad.</span></p><p><span> </span></p><p><strong><span>Otros medicamentos y Biktarvy</span></strong></p><p><span> </span></p><p><strong><span>Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento.</span></strong> <span>Biktarvy puede interaccionar con otros medicamentos.</span> <span>Como consecuencia, los niveles sanguíneos de Biktarvy o de otros medicamentos se pueden ver afectados. Esto puede impedir que sus medicamentos funcionen correctamente o empeorar sus posibles efectos adversos. En algunos casos, su médico puede tener que ajustar la dosis o comprobar sus concentraciones sanguíneas.</span></p><p><span> </span></p><p><a name=\"page3\" id=\"page3\"></a><strong><span>Medicamentos que nunca se deben tomar con Biktarvy:</span></strong></p><p><span> </span></p><ul><li><strong><span>rifampicina</span></strong> <span>utilizada para tratar algunas infecciones bacterianas como la tuberculosis</span></li><li><strong><span>hierba de San Juan</span></strong> <span>(</span><em><span>Hypericum perforatum</span></em><span>, hipérico), un medicamento a base de plantas</span> <span>utilizado para la depresión y la ansiedad, o productos que lo contengan</span><strong><span>.</span></strong></li></ul><p><span> </span></p><ul><li><span>Si está tomando alguno de estos medicamentos,</span> <strong><span>no tome Biktarvy e informe a su médico</span></strong> <strong><span>inmediatamente.</span></strong></li></ul><p><span> </span></p><p><strong><span>Consulte con su médico si está tomando:</span></strong></p><p><span> </span></p><ul><li><strong><span>medicamentos utilizados para tratar el VIH y/o la hepatitis B</span></strong> <span>que contengan:</span></li><li><ul><li><span>adefovir dipivoxil, atazanavir, bictegravir, emtricitabina, lamivudina, tenofovir alafenamida o tenofovir disoproxilo</span></li></ul></li><li><strong><span>antibióticos, utilizados para tratar las infecciones bacterianas</span></strong><span>, que contengan:</span></li><li><div><ul><li><span>azitromicina, claritromicina, rifabutina o rifapentina</span></li></ul></div></li><li><strong><span>antiepilépticos,</span></strong> <span>utilizados para tratar la epilepsia, que contengan:</span></li><li><ul><li><span>carbamazepina, oxcarbazepina, fenobarbital o fenitoína</span></li></ul></li><li><strong><span>inmunosupresores,</span></strong> <span>utilizados para controlar la respuesta inmunitaria del organismo tras un</span> <span>trasplante, que contengan ciclosporina</span></li><li><strong><span>medicamentos para la curación de úlceras</span></strong> <span>que contengan sucralfato</span></li></ul><p><span> </span></p><ul><li><strong><span>Informe a su médico si está tomando alguno de estos medicamentos.</span></strong> <span>No interrumpa su</span> <span>tratamiento sin consultar con su médico.</span></li></ul><p><span> </span></p><p><strong><span>Consulte a su médico o farmacéutico si está tomando:</span></strong></p><ul><li><strong><span>antiácidos</span></strong> <span>para tratar úlceras estomacales, acidez estomacal o reflujo ácido, que contengan</span> <span>hidróxido de aluminio y/o de magnesio</span></li><li><strong><span>suplementos de minerales</span></strong> <span>o</span> <strong><span>de vitaminas,</span></strong> <span>que contengan magnesio o hierro</span></li></ul><p><span> </span></p><div><ul><li><strong><span>Consulte a su médico o farmacéutico antes de tomar Biktarvy</span></strong> <span>si está tomando alguno de estos</span> <span>medicamentos.</span></li></ul></div><p><strong><span>Antiácidos y suplementos de magnesio:</span></strong> <span>tendrá que tomar Biktarvy al menos 2 horas</span> <strong><span>antes</span></strong> <span>de</span> <span>tomar los antiácidos o suplementos que contengan aluminio y/o magnesio. O puede tomar Biktarvy junto con alimentos al menos 2 horas</span> <strong><span>después</span></strong> <span>de la toma del antiácido o suplemento que contenga aluminio y/o magnesio.</span></p><p><strong><span>Suplementos de hierro:</span></strong> <span>tendrá que tomar Biktarvy al menos 2 horas</span> <strong><span>antes</span></strong> <span>de tomar los</span> <span>suplementos de hierro o puede tomarlos todos juntos con alimentos.</span></p><p><span> </span></p><p><strong><span>Embarazo y lactancia</span></strong></p><ul><li><span>Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.</span></li><li><span>Informe a su médico inmediatamente si se queda embarazada y pregunte sobre los posibles beneficios y riesgos de su tratamiento antirretroviral para usted y para su hijo.</span></li></ul><p><span> </span></p><p><span>Si ha tomado Biktarvy durante su embarazo su médico puede solicitar que se haga análisis de sangre periódicos y otras pruebas diagnósticas para controlar el desarrollo de su niño. En niños cuyas madres tomaron nucleósidos inhibidores de la transcriptasa inversa (ITIAN) durante el embarazo, el beneficio de la protección frente al VIH fue mayor que el riesgo de que se produjeran efectos adversos.</span></p><p><span> </span></p><p><strong><span>No dé el pecho a su hijo durante el tratamiento con Biktarvy.</span></strong> <span>Esto se debe a que algunos de los</span> <span>principios activos de este medicamento pasan a la leche materna. Se recomienda que no dé el pecho para evitar que transmita el virus al niño a través de la leche materna. Si realmente desea amamantar, hable primero con su médico.</span></p><p><span> </span></p><p><a name=\"page4\" id=\"page4\"></a><strong><span>Conducción y uso de máquinas</span></strong></p><p><span> </span></p><p><span>Biktarvy puede causar mareo. Si nota mareo durante el tratamiento con Biktarvy, no conduzca ni maneje herramientas o máquinas.</span></p><p><span> </span></p><p><strong><span>Biktarvy contiene sodio</span></strong></p><p><span> </span></p><p><span>Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.</span></p><p><span> </span></p></div>"
}
},
{
"title" : "3. Cómo tomar Karvea",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "3. Cómo tomar Karvea"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><span>Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico.</span></p><p><span>En caso de duda, consulte de nuevo a su médico o farmacéutico.</span></p><p><span> </span></p><p><strong><span>La dosis recomendada es:</span></strong></p><p><span> </span></p><p><strong><span>Adultos:</span></strong> <span>un comprimido al día, con o sin alimentos</span></p><p><span>No mastique, triture ni divida el comprimido.</span></p><p><span> </span></p><ul><li><strong><span>Consulte a su médico o farmacéutico si está tomando:</span></strong></li></ul><ul><li><strong><span>antiácidos</span></strong> <span>para tratar úlceras estomacales, acidez estomacal o reflujo ácido, que contengan</span> <span>hidróxido de aluminio y/o de magnesio</span></li><li><strong><span>suplementos de minerales</span></strong> <span>o</span> <strong><span>vitaminas</span></strong> <span>que contengan magnesio o hierro</span></li></ul><ul><li><strong><span>Vea la sección 2 para más información</span></strong> <span>sobre cómo tomar estos medicamentos con Biktarvy.</span></li></ul><p><span> </span></p><p><strong><span>Si toma más Biktarvy del que debe</span></strong></p><p><span> </span></p><p><span>Si toma más cantidad de la dosis recomendada de Biktarvy puede correr mayor riesgo de experimentar posibles efectos adversos con este medicamento (ver sección 4,</span> <em><span>Posibles efectos adversos</span></em><span>).</span></p><p><span> </span></p><p><span>Consulte inmediatamente a su médico o acuda al servicio de urgencias más cercano. Lleve consigo el frasco de comprimidos para que pueda describir fácilmente qué ha tomado.</span></p><p><span> </span></p><p><strong><span>Si olvidó tomar Biktarvy</span></strong></p><p><span> </span></p><p><span>Es importante que no olvide una dosis de Biktarvy.</span></p><p><span> </span></p><p><span>Si olvida una dosis:</span></p><ul><li><strong><span>Si se da cuenta en las 18 horas</span></strong> <span>posteriores a la hora a la que normalmente toma Biktarvy, debe</span> <span>tomar el comprimido tan pronto como sea posible. Luego tome la dosis siguiente de la forma habitual.</span></li><li><strong><span>Si se da cuenta después de 18 horas o más</span></strong> <span>de la hora a la que normalmente toma Biktarvy, no</span> <span>tome la dosis olvidada. Espere y tome la siguiente dosis a la hora habitual.</span></li></ul><p><span> </span></p><p><strong><span>Si vomita</span></strong> <span>antes de que transcurra 1 hora tras haber tomado Biktarvy, tome otro comprimido. Si</span> <span>vomita transcurrida 1 hora de haber tomado Biktarvy, no necesita tomar otro comprimido hasta el momento de la hora habitual.</span></p><p><span> </span></p><p><strong><span>No interrumpa el tratamiento con Biktarvy</span></strong></p><p><span> </span></p><p><strong><span>No interrumpa el tratamiento con Biktarvy sin hablar antes con su médico.</span></strong> <span>Interrumpir Biktarvy</span> <span>puede afectar gravemente el funcionamiento de tratamientos futuros. Si se interrumpe Biktarvy por algún motivo, consulte con su médico antes de reiniciar la toma de comprimidos de Biktarvy.</span></p><p><span> </span></p><p><a name=\"page5\" id=\"page5\"></a><strong><span>Cuando vea que le queda poca cantidad de Biktarvy,</span></strong> <span>acuda a su médico o farmacéutico para que le</span> <span>proporcione más. Esto es muy importante, ya que la cantidad de virus puede empezar a aumentar si el medicamento se interrumpe incluso durante un corto periodo de tiempo. Es posible que entonces la enfermedad se vuelva más difícil de tratar.</span></p><p><span> </span></p><p><strong><span>Si tiene infección por VIH y hepatitis B</span></strong> <span>es especialmente importante no suspender su tratamiento</span> <span>con Biktarvy sin antes hablar con su médico. Puede necesitar hacerse análisis de sangre durante varios meses tras suspender el tratamiento. En algunos pacientes con enfermedad hepática avanzada o cirrosis no se recomienda suspender el tratamiento ya que esto puede producir un empeoramiento de su hepatitis, situación que puede ser potencialmente mortal.</span></p><p><span> </span></p><ul><li><strong><span>Hable con su médico inmediatamente</span></strong> <span>acerca de síntomas nuevos o inusuales tras suspender su</span> <span>tratamiento, particularmente síntomas que asocie con la infección por el virus de la hepatitis B.</span></li></ul><p><span> </span></p><p><span>Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.</span></p><p><span> </span></p></div>"
}
},
{
"title" : "4. Posibles efectos adversos",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "4. Posibles efectos adversos"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><span> </span></p><p><span>Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.</span></p><p><span> </span></p><p><strong><span>Posibles efectos adversos: informe a un médico inmediatamente</span></strong></p><p><span> </span></p><ul><li><strong><span>Cualquier signo de inflamación o de infección.</span></strong> <span>En algunos pacientes con infección avanzada</span> <span>por el VIH (sida) y antecedentes de infecciones oportunistas (infecciones que ocurren en personas con un sistema inmunitario débil), se pueden producir signos y síntomas de inflamación por infecciones previas poco después de iniciar el tratamiento contra el VIH. Se cree que estos síntomas se deben a una mejoría de la respuesta inmunitaria del organismo, que le permite combatir infecciones que podrían haber estado presentes sin síntomas obvios.</span></li></ul><p><span> </span></p><ul><li><span>Se pueden producir también</span> <strong><span>trastornos autoinmunitarios,</span></strong> <span>en los que el sistema inmunitario ataca a los tejidos sanos del organismo, después de que empiece a tomar medicamentos para la infección por el VIH. Los trastornos autoinmunitarios se pueden producir muchos meses después del inicio del tratamiento. Esté atento a cualquier síntoma de infección u otros síntomas, como:</span></li></ul><p><span> </span></p><div><ul><li><span>debilidad muscular</span></li><li><span>debilidad que se inicia en las manos y los pies y se desplaza hacia el tronco</span></li><li><span>palpitaciones, temblor o hiperactividad</span></li></ul></div><p><span> </span></p><ul><li><strong><span>Si nota cualquiera de estos síntomas o cualquier síntoma de inflamación o infección, informe a su médico inmediatamente.</span></strong></li></ul><p><span> </span></p><p><strong><span>Efectos adversos frecuentes</span></strong></p><p><em><span>(pueden afectar hasta 1 de cada 10 personas)</span></em></p><ul><li><span>depresión</span></li><li><span>sueños anormales</span></li><li><span>dolor de cabeza</span></li><li><span>mareo</span></li><li><span>diarrea</span></li><li><span>ganas de vomitar (</span><em><span>náuseas</span></em><span>)</span></li><li><span>cansancio (</span><em><span>fatiga</span></em><span>)</span></li></ul><p><span> </span></p><p><strong><span>Efectos adversos poco frecuentes</span></strong></p><p><span>(</span><em><span>pueden afectar hasta 1 de cada 100 personas</span></em><span>)</span></p><ul><li><span>anemia</span></li></ul><ul><li><a name=\"page6\" id=\"page6\"></a><span>vómitos</span></li></ul><p><span> </span></p><ul><li><span>dolor de estómago</span></li></ul><p><span> </span></p><ul><li><span>problemas digestivos que generan molestias después de las comidas (</span><em><span>dispepsia</span></em><span>)</span></li></ul><p><span> </span></p><ul><li><span>gases (</span><em><span>flatulencia</span></em><span>)</span></li></ul><p><span> </span></p><ul><li><span>hinchazón de la cara, labios, lengua o garganta (</span><em><span>angioedema</span></em><span>)</span></li></ul><p><span> </span></p><ul><li><span>picazón (</span><em><span>prurito</span></em><span>)</span></li></ul><p><span> </span></p><ul><li><span>erupción</span></li></ul><p><span> </span></p><ul><li><span>habones (</span><em><span>urticaria</span></em><span>)</span></li></ul><p><span> </span></p><ul><li><span>dolor en las articulaciones (</span><em><span>artralgia</span></em><span>)</span></li></ul><p><span> </span></p><ul><li><span>comportamiento suicida</span></li></ul><p><span> </span></p><ul><li><span>ansiedad</span></li></ul><p><span> </span></p><ul><li><span>trastornos del sueño</span></li></ul><p><span> </span></p><p><em><span>Los análisis de sangre también pueden mostrar:</span></em></p><ul><li><span>            </span> <span>Concentraciones más altas de sustancias llamadas bilirrubina y/o creatinina sérica en la sangre</span></li></ul><p><span> </span></p><ul><li><span>        </span> <strong><span>Si considera que alguno de los efectos adversos que sufre es grave, informe a su médico.</span></strong></li></ul><p><strong><span>Otros efectos que se pueden observar durante el tratamiento contra el VIH</span></strong></p><p><span> </span></p><p><span>La frecuencia de los siguientes efectos adversos se considera no conocida (la frecuencia no se puede estimar a partir de los datos disponibles).</span></p><p><span> </span></p><ul><li><strong><span>Problemas óseos.</span></strong> <span>Algunos pacientes tratados con medicamentos antirretrovirales combinados</span> <span>como Biktarvy pueden desarrollar una enfermedad de los huesos llamada</span> <em><span>osteonecrosis</span></em> <span>(muerte del tejido óseo debida a una pérdida del suministro de sangre al hueso). Tomar este tipo de medicamentos durante un tiempo prolongado, tomar corticosteroides, beber alcohol, tener un sistema inmunitario muy débil y tener sobrepeso, pueden ser algunos de los muchos factores de riesgo para desarrollar esta enfermedad. Los signos de osteonecrosis son:</span></li><li><ul><li><span>rigidez articular</span></li><li><span>molestias y dolores articulares (especialmente de la cadera, la rodilla y el hombro)</span></li><li><span>dificultad para moverse</span></li></ul></li></ul><p><span> </span></p><ul><li><strong><span>Si nota cualquiera de estos síntomas, informe a su médico.</span></strong></li></ul><p><span> </span></p><p><span>Durante el tratamiento del VIH puede haber un aumento en el peso y en los niveles de glucosa y lípidos en la sangre. Esto puede estar en parte relacionado con la recuperación de la salud y con el estilo de vida y, en el caso de los lípidos en la sangre, algunas veces con los medicamentos contra el VIH por sí mismos. Su médico le controlará estos cambios.</span></p><p><span> </span></p><p><strong><span>Comunicación de efectos adversos</span></strong></p><p><span> </span></p><p><span>Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente</span> <span>a través del sistema nacional de notificación incluido en el</span> <a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span>Apéndice V.</span></a> <span>Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.</span></p><p><span> </span></p><p><span> </span></p></div>"
}
},
{
"title" : "5. Conservación de Karvea",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "5. Conservación de Karvea"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><span>Mantener este medicamento fuera de la vista y del alcance de los niños.</span></p><p><span> </span></p><p><span>No utilice este medicamento después de la fecha de caducidad que aparece en la caja y en el frasco después de {CAD}. La fecha de caducidad es el último día del mes que se indica.</span></p><p><span> </span></p><p><span>Conservar en el embalaje original para protegerlo de la humedad. Mantener el frasco perfectamente cerrado. No utilizar si falta el sello del frasco o está roto.</span></p><p><span> </span></p><p><a name=\"page7\" id=\"page7\"></a><span>Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.</span></p><p><span> </span></p></div>"
}
},
{
"title" : "6. Contenido del envase e información adicional",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "6. Contenido del envase e información adicional"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Karvea indeholder:</p><ul><li>Aktivt stof: irbesartan. Hver Karvea-tablet 75 mg indeholder 75 mg irbesartan.</li><li>Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, croscarmellosenatrium, magnesiumstearat, kolloid silica, prægelatineret majsstivelse, poloaxamer 188.<br/>Se punkt 2 ”Aprovel indeholder lactose”</li></ul><p>Udseende og pakningstørrelser Karvea 75 mg tabletter er hvide til mathvide, bikonvekse og ovale med et hjerte præget på den ene side og nummeret 2771 på den anden side.</p><p>Karvea 75 mg tabletter leveres i blisterpakninger af 14, 28, 56 eller 98 tabletter. Der fås også enkeltdosisblisterpakninger med 56 x 1 tablet til hospitalsbrug.</p><p>Ikke alle pakningsstørrelser er nødvendigvis markedsført.</p><p>Indehaveren af markedsføringstilladelsen:</p><p>Sanofi Winthrop Industrie 82 avenue Raspail 94250 Gentilly Frankrig</p><p>Fremstiller:</p><p>SANOFI WINTHROP INDUSTRIE 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc Cedex - Frankrig</p><p>SANOFI WINTHROP INDUSTRIE 30-36 Avenue Gustave Eiffel, BP 7F-37071 Tours Cedex 2 - Frankrig</p><p>Hvis du vil have yderligere oplysninger om Karvea, skal du henvende dig til den lokale repræsentant for indehaveren af markedsføringstilladelsen:</p><p>België/Belgique/Belgien Sanofi Belgium Tél/Tel: +32 (0)2 710 54<br/>Lietuva Swixx Biopharma UAB Tel: +370 5 236 91<br/>България Swixx Biopharma EOOD Тел.: +359 (0)2 4942<br/>Luxembourg/Luxemburg Sanofi Belgium<br/>Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)</p><p>Česká republika sanofi-aventis, s.r.o. Tel: +420 233 086<br/>Magyarország SANOFI-AVENTIS Zrt. Tel.: +36 1 505 0 Danmark Sanofi A/S Tlf: +45 45 16 70<br/>Malta Sanofi S.r.l. Tel: +39 02 39394</p><p>Deutschland Sanofi-Aventis Deutschland GmbH Tel: 0800 52 52 Tel. aus dem Ausland: +49 69 305 21<br/>Nederland Sanofi B.V. Tel: +31 20 245 4 Eesti Swixx Biopharma OÜ Tel: +372 640 10<br/>Norge sanofi-aventis Norge AS Tlf: +47 67 10 71<br/>Ελλάδα Sanofi-Aventis Μονοπρόσωπη AEBE Τηλ: +30 210 900 16<br/>Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0</p><p>España sanofi-aventis, S.A. Tel: +34 93 485 94<br/>Polska sanofi-aventis Sp. z o.o. Tel.: +48 22 280 00<br/>France Sanofi Winthrop Industrie Tél:<br/>0 800 222 Appel depuis l’étranger : +33 1 57 63 23<br/>Portugal Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89<br/>Hrvatska Swixx Biopharma d.o.o. Tel: +385 1 2078 România Sanofi Romania SRL Tel: +40 (0) 21 317 31<br/>Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56<br/>Slovenija Swixx Biopharma d.o.o. Tel: +386 1 235 51<br/>Ísland Vistor hf. Sími: +354 535 7 Slovenská republika Swixx Biopharma s.r.o. Tel: +421 2 208 33<br/>Italia Sanofi S.r.l. Tel: 800.536 Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200<br/>Κύπρος C.A. Papaellinas Ltd. Τηλ: +357 22 741 Sverige Sanofi AB Tel: +46 (0)8 634 50<br/>Latvija Swixx Biopharma SIA Tel: +371 6 616 47<br/>United Kingdom (Northern Ireland) sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2 Denne indlægsseddel blev senest ændret</p><p>Du kan finde yderligere information om Karvea på Det Europæiske Lægemiddelagenturs hjemmeside</p></div>"
}
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/cud-a40c2367ed3c1c715eacd432105752a0",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-a40c2367ed3c1c715eacd432105752a0",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-a40c2367ed3c1c715eacd432105752a0\"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"cud-a40c2367ed3c1c715eacd432105752a0\"> </a><a name=\"hccud-a40c2367ed3c1c715eacd432105752a0\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceClinicalUseDefinition "cud-a40c2367ed3c1c715eacd432105752a0" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html\">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>type</b>: contraindication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Diabetis Mellitus <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (mdr#10012601)</span></td></tr></table></blockquote></div>"
},
"type" : "contraindication",
"subject" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"contraindication" : {
"diseaseSymptomProcedure" : {
"concept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/mdr",
"code" : "10012601",
"display" : "Diabetis Mellitus"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/cud-585e364c14debe29f6c6b564138aa400",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-585e364c14debe29f6c6b564138aa400",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-585e364c14debe29f6c6b564138aa400\"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"cud-585e364c14debe29f6c6b564138aa400\"> </a><a name=\"hccud-585e364c14debe29f6c6b564138aa400\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceClinicalUseDefinition "cud-585e364c14debe29f6c6b564138aa400" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-indication-uv-epi.html\">ClinicalUseDefinition Indication (ePI)</a></p></div><p><b>type</b>: indication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Hypertension <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (mdr#10020772)</span></td></tr></table></blockquote></div>"
},
"type" : "indication",
"subject" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"indication" : {
"diseaseSymptomProcedure" : {
"concept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/mdr",
"code" : "10020772",
"display" : "Hypertension"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/cud-4fce9d5258f70f7d605059f97c24efa8",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-4fce9d5258f70f7d605059f97c24efa8",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-4fce9d5258f70f7d605059f97c24efa8\"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"cud-4fce9d5258f70f7d605059f97c24efa8\"> </a><a name=\"hccud-4fce9d5258f70f7d605059f97c24efa8\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceClinicalUseDefinition "cud-4fce9d5258f70f7d605059f97c24efa8" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html\">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>type</b>: interaction</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>METHOTREXATE <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#YL5FZ2Y5U1)</span></td></tr></table></blockquote></div>"
},
"type" : "interaction",
"subject" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"interaction" : {
"interactant" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "YL5FZ2Y5U1",
"display" : "METHOTREXATE"
}
]
}
}
]
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-hypromellose",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-hypromellose",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-hypromellose\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-hypromellose\"> </a><a name=\"hcingredient-for-karvea-hypromellose\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-hypromellose" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/3NXW29V3WO\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Hypromellose <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#3NXW29V3WO)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "3NXW29V3WO"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "3NXW29V3WO",
"display" : "Hypromellose"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-macrogol3000",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-macrogol3000",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-macrogol3000\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-macrogol3000\"> </a><a name=\"hcingredient-for-karvea-macrogol3000\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-macrogol3000" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/SA1B764746\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Macrogol 3000 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#SA1B764746)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "SA1B764746"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "SA1B764746",
"display" : "Macrogol 3000"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-lactosemonohydrate",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-lactosemonohydrate",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-lactosemonohydrate\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-lactosemonohydrate\"> </a><a name=\"hcingredient-for-karvea-lactosemonohydrate\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-lactosemonohydrate" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/EWQ57Q8I5X\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Lactose Monohydrate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#EWQ57Q8I5X)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "EWQ57Q8I5X"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "EWQ57Q8I5X",
"display" : "Lactose Monohydrate"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-silicondioxide",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-silicondioxide",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-silicondioxide\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-silicondioxide\"> </a><a name=\"hcingredient-for-karvea-silicondioxide\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-silicondioxide" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/ETJ7Z6XBU4\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Silicon dioxide <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#ETJ7Z6XBU4)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "ETJ7Z6XBU4"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "ETJ7Z6XBU4",
"display" : "Silicon dioxide"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-titaniumdioxide",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-titaniumdioxide",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-titaniumdioxide\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-titaniumdioxide\"> </a><a name=\"hcingredient-for-karvea-titaniumdioxide\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-titaniumdioxide" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/15FIX9V2JP\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Titanium Dioxide <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#15FIX9V2JP)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "15FIX9V2JP"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "15FIX9V2JP",
"display" : "Titanium Dioxide"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-irbesartan",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-irbesartan",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-irbesartan\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-irbesartan\"> </a><a name=\"hcingredient-for-karvea-irbesartan\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-irbesartan" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/J0E2756Z7N\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>irbesartan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#J0E2756Z7N)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style=\"display: none\">*</td><td>75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "J0E2756Z7N"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072072",
"display" : "active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "J0E2756Z7N",
"display" : "irbesartan"
}
]
}
},
"strength" : [
{
"presentationQuantity" : {
"value" : 75,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"basis" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
"code" : "ACTIB",
"display" : "active ingredient - basis of strength"
}
]
}
}
]
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-croscarmellosesodium",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-croscarmellosesodium",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-croscarmellosesodium\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-croscarmellosesodium\"> </a><a name=\"hcingredient-for-karvea-croscarmellosesodium\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-croscarmellosesodium" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/M28OL1HH48\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Croscarmellose sodium <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#M28OL1HH48)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "M28OL1HH48"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "M28OL1HH48",
"display" : "Croscarmellose sodium"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-microcrystallinecellulose",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-microcrystallinecellulose",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-microcrystallinecellulose\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-microcrystallinecellulose\"> </a><a name=\"hcingredient-for-karvea-microcrystallinecellulose\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-microcrystallinecellulose" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/OP1R32D61U\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Microcrystalline cellulose <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#OP1R32D61U)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "OP1R32D61U"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "OP1R32D61U",
"display" : "Microcrystalline cellulose"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-magnesiumstearate",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-magnesiumstearate",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-magnesiumstearate\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-magnesiumstearate\"> </a><a name=\"hcingredient-for-karvea-magnesiumstearate\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-magnesiumstearate" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/70097M6I30\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Magnesium stearate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#70097M6I30)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "70097M6I30"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "70097M6I30",
"display" : "Magnesium stearate"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-carnaubawax",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-for-karvea-carnaubawax",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-for-karvea-carnaubawax\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredient-for-karvea-carnaubawax\"> </a><a name=\"hcingredient-for-karvea-carnaubawax\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceIngredient "ingredient-for-karvea-carnaubawax" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/R12CBM0EIZ\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Carnauba wax <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#R12CBM0EIZ)</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"value" : "R12CBM0EIZ"
},
"status" : "active",
"for" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
},
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
},
{
"reference" : "AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
"code" : "R12CBM0EIZ",
"display" : "Carnauba wax"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-irbesartan",
"resource" : {
"resourceType" : "SubstanceDefinition",
"id" : "substance-irbesartan",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"SubstanceDefinition_substance-irbesartan\"> </a><p><b>Generated Narrative: SubstanceDefinition</b><a name=\"substance-irbesartan\"> </a><a name=\"hcsubstance-irbesartan\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceSubstanceDefinition "substance-irbesartan" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-SubstanceDefinition-uv-epi.html\">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta/</code>/J0E2756Z7N\u00a0(use:\u00a0official)</p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>description</b>: White to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.</p><p><b>manufacturer</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p><h3>MolecularWeights</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td style=\"display: none\">*</td><td>exact <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></td><td>428.53</td></tr></table><h3>Structures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>MolecularFormula</b></td></tr><tr><td style=\"display: none\">*</td><td>C25H28N6O</td></tr></table><h3>Names</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style=\"display: none\">*</td><td>(+)-6-methyleneandrosta-1,4-diene-3,17-dione</td><td>Chemical Name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#x)</span></td></tr></table></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"value" : "J0E2756Z7N"
}
],
"version" : "1",
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active"
}
]
},
"description" : "White to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.",
"manufacturer" : [
{
"reference" : "Organization/mah-511671db37e83e520b00f8a0d817dc96"
}
],
"molecularWeight" : [
{
"type" : {
"text" : "exact"
},
"amount" : {
"value" : 428.53
}
}
],
"structure" : {
"molecularFormula" : "C25H28N6O"
},
"name" : [
{
"name" : "(+)-6-methyleneandrosta-1,4-diene-3,17-dione",
"type" : {
"coding" : [
{
"system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
"code" : "x",
"display" : "Chemical Name"
}
]
}
}
]
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee",
"resource" : {
"resourceType" : "AdministrableProductDefinition",
"id" : "ap-dcaa4d32aa6658a8df831551503e52ee",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AdministrableProductDefinition_ap-dcaa4d32aa6658a8df831551503e52ee\"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name=\"ap-dcaa4d32aa6658a8df831551503e52ee\"> </a><a name=\"hcap-dcaa4d32aa6658a8df831551503e52ee\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceAdministrableProductDefinition "ap-dcaa4d32aa6658a8df831551503e52ee" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html\">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>administrableDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073664)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000002152)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td>Human <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/001"
}
],
"status" : "active",
"formOf" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000002152",
"display" : "Tablet"
}
]
},
"producedFrom" : [
{
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073619",
"display" : "Oral use"
}
]
},
"targetSpecies" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000109093",
"display" : "Human"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee0",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "authorizationdcaa4d32aa6658a8df831551503e52ee0",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee0\"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authorizationdcaa4d32aa6658a8df831551503e52ee0\"> </a><a name=\"hcauthorizationdcaa4d32aa6658a8df831551503e52ee0\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee0" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/010\u00a0(use:\u00a0official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-d91b269b209aaa5538a1bfafd1a7434d</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/010"
}
],
"subject" : [
{
"reference" : "PackagedProductDefinition/ppd-d91b269b209aaa5538a1bfafd1a7434d"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"holder" : {
"reference" : "Organization/mah-511671db37e83e520b00f8a0d817dc96"
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee1",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "authorizationdcaa4d32aa6658a8df831551503e52ee1",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee1\"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authorizationdcaa4d32aa6658a8df831551503e52ee1\"> </a><a name=\"hcauthorizationdcaa4d32aa6658a8df831551503e52ee1\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee1" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001\u00a0(use:\u00a0official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-f3f2f89544dfc5d20216861bcf90c0c5</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/001"
}
],
"subject" : [
{
"reference" : "PackagedProductDefinition/ppd-f3f2f89544dfc5d20216861bcf90c0c5"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"holder" : {
"reference" : "Organization/mah-511671db37e83e520b00f8a0d817dc96"
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee2",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "authorizationdcaa4d32aa6658a8df831551503e52ee2",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee2\"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authorizationdcaa4d32aa6658a8df831551503e52ee2\"> </a><a name=\"hcauthorizationdcaa4d32aa6658a8df831551503e52ee2\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee2" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/002\u00a0(use:\u00a0official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-5763619e2b501aeeab53677bd09d5cbf</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/002"
}
],
"subject" : [
{
"reference" : "PackagedProductDefinition/ppd-5763619e2b501aeeab53677bd09d5cbf"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"holder" : {
"reference" : "Organization/mah-511671db37e83e520b00f8a0d817dc96"
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee3",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "authorizationdcaa4d32aa6658a8df831551503e52ee3",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee3\"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authorizationdcaa4d32aa6658a8df831551503e52ee3\"> </a><a name=\"hcauthorizationdcaa4d32aa6658a8df831551503e52ee3\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee3" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/003\u00a0(use:\u00a0official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-9b1d5d261d22694685deb35714ec08ea</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/003"
}
],
"subject" : [
{
"reference" : "PackagedProductDefinition/ppd-9b1d5d261d22694685deb35714ec08ea"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"holder" : {
"reference" : "Organization/mah-511671db37e83e520b00f8a0d817dc96"
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-511671db37e83e520b00f8a0d817dc96",
"resource" : {
"resourceType" : "Organization",
"id" : "mah-511671db37e83e520b00f8a0d817dc96",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_mah-511671db37e83e520b00f8a0d817dc96\"> </a><p><b>Generated Narrative: Organization</b><a name=\"mah-511671db37e83e520b00f8a0d817dc96\"> </a><a name=\"hcmah-511671db37e83e520b00f8a0d817dc96\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceOrganization "mah-511671db37e83e520b00f8a0d817dc96" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/ORG-100011564\u00a0(use:\u00a0official)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000034)</span></p><p><b>name</b>: Sanofi Winthrop Industrie\t</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td>82 avenue Raspail Gentilly FR(work)</td></tr></table></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/omswi",
"value" : "ORG-100011564"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000034",
"display" : "Marketing authorisation holder"
}
]
}
],
"name" : "Sanofi Winthrop Industrie\t",
"contact" : [
{
"address" : {
"use" : "work",
"type" : "physical",
"text" : "82 avenue Raspail Gentilly FR",
"line" : [
"82 avenue Raspail"
],
"city" : "Gentilly",
"postalCode" : "94250",
"country" : "FR"
}
}
]
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/Organization/man-4bb7a752921434fd5f9921b5b9473eda",
"resource" : {
"resourceType" : "Organization",
"id" : "man-4bb7a752921434fd5f9921b5b9473eda",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_man-4bb7a752921434fd5f9921b5b9473eda\"> </a><p><b>Generated Narrative: Organization</b><a name=\"man-4bb7a752921434fd5f9921b5b9473eda\"> </a><a name=\"hcman-4bb7a752921434fd5f9921b5b9473eda\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceOrganization "man-4bb7a752921434fd5f9921b5b9473eda" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/ORG-100011564\u00a0(use:\u00a0official)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000033)</span></p><p><b>name</b>: Sanofi Winthrop Industrie</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td>1, rue de la Vierge Ambarès & Lagrave FR(work)</td></tr></table></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/omswi",
"value" : "ORG-100011564"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000033",
"display" : "Manufacturer"
}
]
}
],
"name" : "Sanofi Winthrop Industrie",
"contact" : [
{
"address" : {
"use" : "work",
"type" : "physical",
"text" : "1, rue de la Vierge Ambarès & Lagrave FR",
"line" : [
"1, rue de la Vierge"
],
"city" : "Ambarès & Lagrave",
"postalCode" : "33565",
"country" : "FR"
}
}
]
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-d91b269b209aaa5538a1bfafd1a7434d",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "ppd-d91b269b209aaa5538a1bfafd1a7434d",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_ppd-d91b269b209aaa5538a1bfafd1a7434d\"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"ppd-d91b269b209aaa5538a1bfafd1a7434d\"> </a><a name=\"hcppd-d91b269b209aaa5538a1bfafd1a7434d\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePackagedProductDefinition "ppd-d91b269b209aaa5538a1bfafd1a7434d" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/010\u00a0(use:\u00a0official)</p><p><b>name</b>: Karvea 75 mg tablet 14</p><p><b>type</b>: Chemical Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 14</p><p><b>material</b>: PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/010"
}
],
"name" : "Karvea 75 mg tablet 14",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000155527",
"display" : "Chemical Medicinal Product"
}
]
},
"packageFor" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"containedItemQuantity" : [
{
"value" : 75,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
],
"manufacturer" : [
{
"reference" : "Organization/man-4bb7a752921434fd5f9921b5b9473eda"
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "123456"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073496",
"display" : "Blister"
}
]
},
"quantity" : 14,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003222",
"display" : "PolyVinyl Chloride"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-f3f2f89544dfc5d20216861bcf90c0c5",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "ppd-f3f2f89544dfc5d20216861bcf90c0c5",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_ppd-f3f2f89544dfc5d20216861bcf90c0c5\"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"ppd-f3f2f89544dfc5d20216861bcf90c0c5\"> </a><a name=\"hcppd-f3f2f89544dfc5d20216861bcf90c0c5\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePackagedProductDefinition "ppd-f3f2f89544dfc5d20216861bcf90c0c5" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001\u00a0(use:\u00a0official)</p><p><b>name</b>: Karvea 75 mg tablet 28</p><p><b>type</b>: Chemical Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 28</p><p><b>material</b>: PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/001"
}
],
"name" : "Karvea 75 mg tablet 28",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000155527",
"display" : "Chemical Medicinal Product"
}
]
},
"packageFor" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"containedItemQuantity" : [
{
"value" : 75,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
],
"manufacturer" : [
{
"reference" : "Organization/man-4bb7a752921434fd5f9921b5b9473eda"
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "123456"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073496",
"display" : "Blister"
}
]
},
"quantity" : 28,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003222",
"display" : "PolyVinyl Chloride"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-5763619e2b501aeeab53677bd09d5cbf",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "ppd-5763619e2b501aeeab53677bd09d5cbf",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_ppd-5763619e2b501aeeab53677bd09d5cbf\"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"ppd-5763619e2b501aeeab53677bd09d5cbf\"> </a><a name=\"hcppd-5763619e2b501aeeab53677bd09d5cbf\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePackagedProductDefinition "ppd-5763619e2b501aeeab53677bd09d5cbf" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/002\u00a0(use:\u00a0official)</p><p><b>name</b>: Karvea 75 mg tablet 56</p><p><b>type</b>: Chemical Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 56</p><p><b>material</b>: PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/002"
}
],
"name" : "Karvea 75 mg tablet 56",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000155527",
"display" : "Chemical Medicinal Product"
}
]
},
"packageFor" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"containedItemQuantity" : [
{
"value" : 75,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
],
"manufacturer" : [
{
"reference" : "Organization/man-4bb7a752921434fd5f9921b5b9473eda"
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "123456"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073496",
"display" : "Blister"
}
]
},
"quantity" : 56,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003222",
"display" : "PolyVinyl Chloride"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-9b1d5d261d22694685deb35714ec08ea",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "ppd-9b1d5d261d22694685deb35714ec08ea",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_ppd-9b1d5d261d22694685deb35714ec08ea\"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"ppd-9b1d5d261d22694685deb35714ec08ea\"> </a><a name=\"hcppd-9b1d5d261d22694685deb35714ec08ea\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourcePackagedProductDefinition "ppd-9b1d5d261d22694685deb35714ec08ea" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/003\u00a0(use:\u00a0official)</p><p><b>name</b>: Karvea 75 mg tablet 98</p><p><b>type</b>: Chemical Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 98</p><p><b>material</b>: PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/003"
}
],
"name" : "Karvea 75 mg tablet 98",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000155527",
"display" : "Chemical Medicinal Product"
}
]
},
"packageFor" : [
{
"reference" : "MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"statusDate" : "2015-02-07T13:28:17Z",
"containedItemQuantity" : [
{
"value" : 75,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
],
"manufacturer" : [
{
"reference" : "Organization/man-4bb7a752921434fd5f9921b5b9473eda"
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "123456"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073496",
"display" : "Blister"
}
]
},
"quantity" : 98,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000003222",
"display" : "PolyVinyl Chloride"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
"reference" : "ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "mp873a1a47330e628770640f9c96c0761e",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mp873a1a47330e628770640f9c96c0761e\"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name=\"mp873a1a47330e628770640f9c96c0761e\"> </a><a name=\"hcmp873a1a47330e628770640f9c96c0761e\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceMedicinalProductDefinition "mp873a1a47330e628770640f9c96c0761e" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001, <code>https://www.who-umc.org/phpid</code>/0xF79CABF272B6A7EEF104DDDA44E82719</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html\">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html\">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Karvea 75 mg tablet</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Karvea</p><p><b>type</b>: Invented name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: irbesartan</p><p><b>type</b>: Scientific name part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 75 mg</p><p><b>type</b>: Strength part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: tablet</p><p><b>type</b>: Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td>Denmark <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#DK)</span></td><td>Denmark <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#DK)</span></td><td>English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/001"
},
{
"system" : "https://www.who-umc.org/phpid",
"value" : "0xF79CABF272B6A7EEF104DDDA44E82719"
}
],
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-type",
"code" : "MedicinalProduct",
"display" : "Medicinal Product"
}
]
},
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "active"
}
]
},
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"name" : [
{
"productName" : "Karvea 75 mg tablet",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000001",
"display" : "Full name"
}
]
},
"part" : [
{
"part" : "Karvea",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000002",
"display" : "Invented name part"
}
]
}
},
{
"part" : "irbesartan",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000003",
"display" : "Scientific name part"
}
]
}
},
{
"part" : "75 mg",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "tablet",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "DK",
"display" : "Denmark"
}
]
},
"jurisdiction" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "DK",
"display" : "Denmark"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "English"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "mid-dcaa4d32aa6658a8df831551503e52ee",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_mid-dcaa4d32aa6658a8df831551503e52ee\"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name=\"mid-dcaa4d32aa6658a8df831551503e52ee\"> </a><a name=\"hcmid-dcaa4d32aa6658a8df831551503e52ee\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceManufacturedItemDefinition "mid-dcaa4d32aa6658a8df831551503e52ee" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html\">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000073664)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000002152)</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p></div>"
},
"identifier" : [
{
"use" : "official",
"system" : "https://spor.ema.europa.eu/pmswi",
"value" : "EU/1/97/049/001"
}
],
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000002152",
"display" : "Tablet"
}
]
},
"manufacturer" : [
{
"reference" : "Organization/man-4bb7a752921434fd5f9921b5b9473eda"
}
]
}
}
]
}
IG © 2021+ Gravitate Health Project. Package hl7.eu.fhir.gh#0.1.0 based on FHIR 5.0.0. Generated 2024-05-15
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
